Becton Dickinson recalls blood glucose test strips:
This article was originally published in Clinica
Executive Summary
Becton Dickinson has recalled certain lots of its BD test strips used in blood glucose monitoring. It says the affected lots are associated with an increased frequency of an error message on the meter. The company stressed that the problem would not lead to erroneous test results, as no result is displayed when the "E-3" message in question is displayed. It says it has sufficient strips available to replace recalled products and continue supplying the market.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.